Clinical effects of intravenous iloprost in patients with intermittent claudication

U. Müller-Bühl; C. Diehm; T. Krais; R. Zimmermann; H. Mörl; H. H. Eckstein

doi:10.1007/BF00544555

Clinical effects of intravenous iloprost in patients with intermittent claudication

U. Müller-Bühl
, C. Diehm
, T. Krais
, R. Zimmermann
, H. Mörl
, H. H. Eckstein

Heidelberg University
Therapeutic Research Group Women's Healthcare Bayer Schering Pharma AG
Diakonissenkrankenhaus

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

In a randomized patient-blind study iloprost or hydroxy-ethyl starch 200/0.5 were given i.v. 5 h daily for 2 weeks to 24 patients suffering from severe intermittent claudication due to peripheral vascular disease. An increase in pain-free walking distance of more than 50% occurred in 6 of 11 patients after the iloprost infusions and in 7 of 12 patients after HES treatment. No significant effects on haemodynamic or clinical chemistry tests were observed.

Original language	English
Pages (from-to)	127-131
Number of pages	5
Journal	European Journal of Clinical Pharmacology
Volume	33
Issue number	2
DOIs	https://doi.org/10.1007/BF00544555
State	Published - Mar 1987
Externally published	Yes

Keywords

clinical effects
haemodynamics
hydroxyethyl starch
iloprost
intermittent claudication

Access to Document

10.1007/BF00544555

Cite this

@article{212735164dd04da49f298c2ddb270ba6,

title = "Clinical effects of intravenous iloprost in patients with intermittent claudication",

abstract = "In a randomized patient-blind study iloprost or hydroxy-ethyl starch 200/0.5 were given i.v. 5 h daily for 2 weeks to 24 patients suffering from severe intermittent claudication due to peripheral vascular disease. An increase in pain-free walking distance of more than 50\% occurred in 6 of 11 patients after the iloprost infusions and in 7 of 12 patients after HES treatment. No significant effects on haemodynamic or clinical chemistry tests were observed.",

keywords = "clinical effects, haemodynamics, hydroxyethyl starch, iloprost, intermittent claudication",

author = "U. M{\"u}ller-B{\"u}hl and C. Diehm and T. Krais and R. Zimmermann and H. M{\"o}rl and Eckstein, \{H. H.\}",

year = "1987",

month = mar,

doi = "10.1007/BF00544555",

language = "English",

volume = "33",

pages = "127--131",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - Clinical effects of intravenous iloprost in patients with intermittent claudication

AU - Müller-Bühl, U.

AU - Diehm, C.

AU - Krais, T.

AU - Zimmermann, R.

AU - Mörl, H.

AU - Eckstein, H. H.

PY - 1987/3

Y1 - 1987/3

N2 - In a randomized patient-blind study iloprost or hydroxy-ethyl starch 200/0.5 were given i.v. 5 h daily for 2 weeks to 24 patients suffering from severe intermittent claudication due to peripheral vascular disease. An increase in pain-free walking distance of more than 50% occurred in 6 of 11 patients after the iloprost infusions and in 7 of 12 patients after HES treatment. No significant effects on haemodynamic or clinical chemistry tests were observed.

AB - In a randomized patient-blind study iloprost or hydroxy-ethyl starch 200/0.5 were given i.v. 5 h daily for 2 weeks to 24 patients suffering from severe intermittent claudication due to peripheral vascular disease. An increase in pain-free walking distance of more than 50% occurred in 6 of 11 patients after the iloprost infusions and in 7 of 12 patients after HES treatment. No significant effects on haemodynamic or clinical chemistry tests were observed.

KW - clinical effects

KW - haemodynamics

KW - hydroxyethyl starch

KW - iloprost

KW - intermittent claudication

UR - https://www.scopus.com/pages/publications/0023233260

U2 - 10.1007/BF00544555

DO - 10.1007/BF00544555

M3 - Article

C2 - 2446877

AN - SCOPUS:0023233260

SN - 0031-6970

VL - 33

SP - 127

EP - 131

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 2

ER -

Clinical effects of intravenous iloprost in patients with intermittent claudication

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this